Study on Vulnerable Plaque of Carotid Artery With Chinese Herbal and Insects Medicine
NCT ID: NCT03072225
Last Updated: 2017-03-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
120 participants
INTERVENTIONAL
2017-03-31
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Proteomic Study and Early Intervention Study of Carotid Unstable Plaque
NCT05622877
Chinese Atherosclerosis Risk Evaluation- Phase II
NCT02017756
Prevention for the Restenosis of Intracranial Artery Stent Implantation Treated With Herbal Medicine C117
NCT03008798
Investigation of Multiple Ultrasound Techniques for the Assessment of Carotid Plaque Vulnerability
NCT04530721
Heat-clearing and Blood-activating Chinese Medicinal Components in Acute Cerebral Infarction
NCT02544087
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Herbal Medicine C-117
Herbal Medicine C-117 Prescription (6g/bag,one bag each time, twice a day.) for 6 months
Herbal Medicine C-117
Herbal Medicine C-117 formula including 2 herbals and 2 insects
The Placebo of Herbal Medicine C-117
Placebo of Herbal Medicine C-117 (6g/bag,one bag each time, twice a day.) for 6 months
The Placebo of Herbal Medicine C-117
The Placebo of Herbal Medicine C-117 formula including 4 herbals
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Herbal Medicine C-117
Herbal Medicine C-117 formula including 2 herbals and 2 insects
The Placebo of Herbal Medicine C-117
The Placebo of Herbal Medicine C-117 formula including 4 herbals
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Ultrasound of carotid artery atherosclerosis plaque specifies it as unstable plaque (including malacoplakia and mixed plaque);
Exclusion Criteria
2. Carotid artery stenosis is higher than or equal to 50%;
3. Confirmed as or suspected to be vasculitis;
4. With infection, tumor or insufficient heart, liver and kidney functions (renal function higher than twice of upper limit in normal limit, HYHA heart function grading higher than or equal to level 2 );
5. With acute myocardial infarction and unstable angina pectoris;
6. With acute cerebral arterial thrombosis;
7. lesion: Severe stenosis or occlusion of distal intracranial vessels;
8. Pregnant women or lactating mothers;
9. With known history of allergy to the drugs of the trial.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Guangzhou University of Traditional Chinese Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jianwen Guo, MD
Role: PRINCIPAL_INVESTIGATOR
Guangdong Province Hospital of Tradtional Chinese Medicine
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Gong B, Chen X, Lin R, Zhang F, Zhong J, Zhang Q, Zhou Y, Li H, Zeng L, Jiang Z, Guo J. Safety and Efficacy of the C-117 Formula for Vulnerable Carotid Artery Plaques (Spchim): A Randomized Double-Blind Controlled Pilot Study. Evid Based Complement Alternat Med. 2019 Jul 17;2019:9746492. doi: 10.1155/2019/9746492. eCollection 2019.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
YN2014LN08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.